Covid-19. To develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93020C00053
- Awardee
-
Colorado State University UEI LT9CXX8L19G1 Part of Colorado State University System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,252,060
Award facts
- Opportunity
-
- 2020 NIAID Omnibus Broad Agency Announcement Pre-Solicitation · HHSNIHNIAIDBAA20201 · Posted Dec 11, 2019
- COVID-19: HHS-NIH-NIAID-BAA2020-1: Research Area 003, Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Aug 21, 2020
- 2020 NIAID Omnibus Broad Agency Announcement Solicitation · Posted Jan 3, 2020
- Contract value 33% obligated
-
- $6,252,059.89 Current, with exercised options
- $19,189,251.89 Potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 23 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Fort Collins, CO 80523, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$28,751 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $850,444 | |
| Funding Only Action | $781,429 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $180,486 | |
| Exercise an Option | $1,369,421 | |
| Original award | $3,099,031 |
Show all 21
About this award
The National Institute of Allergy and Infectious Diseases awarded a $19.2 million definitive contract to Colorado State University's Sponsored Programs division on September 1, 2020, to develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology under an Executive Order 14398 directive addressing COVID-19.
Place of performance is Fort Collins, Colorado. The originating pre-solicitation, posted December 11, 2019, solicited proposals for advanced vaccine and therapeutic candidates, medical countermeasures, and diagnostics targeting infectious diseases. Performance extends through April 30, 2028.
Subcontractors include Charles River Laboratories (laboratory animal models and vaccine candidate preparation), Bioreliance Corporation (microbiological and biochemical testing services), and Fisher Scientific (laboratory equipment and supplies).
Service Contract Inventory data shows declining government-paid hourly rates across the performance period. FY2021 through FY2025 invoicing totaled $5.9 million across a cumulative 24.4 FTEs and 50,817 contractor hours. Derived government-paid rates declined from $109.79 per hour in FY2021 to $90.78 per hour in FY2025. The most recent reported fiscal year (FY2025) deployed 4.7 FTEs across 9,797 contractor hours, with 10 percent of contractor hours subcontracted.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Charles River Laboratories, Inc. | $8,615 | |
| Fisher Scientific Company L.L.C. | $1,935 | |
| Bioreliance Corporation | $62,924 | |
| Charles River Laboratories, Inc. | $74,720 | |
| Fisher Scientific Company L.L.C. | $1,266 |
Quick answers
Who was awarded contract 75N93020C00053?
75N93020C00053 was awarded to Colorado State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.
How much is contract 75N93020C00053 worth?
The government has obligated $6,252,060 on 75N93020C00053. Its potential value, with all options, is $19,189,252.
Was contract 75N93020C00053 competed?
The extent of competition for 75N93020C00053 was full and open competition. The government received 23 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award